It was revealed that the high expression of SLC35A2 and advanced clinical stages were highly relevant in 18 cancers, including STAD, PAAD, LUAD, KIRC, ESCA, BRCA, thyroid cancer (THCA), TGCT, READ, LUSC, KIRP, HNSC, ACC, SKCM, LIHC, kidney chromophobe (KICH), COAD, and BLCA (Supplementary Figure 6). The gene discussed is SLC35A2; the disease is thyroid cancer.